Subject expert committee

Expert panel approves Bharat Biotech's children's vaccine for trials 12 May 2021

Expert panel approves Bharat Biotech's children's vaccine for trials:- Bharat Biotech's Covaxin has been recommended by the expert panel for the second and third phase of clinical trials for the children aged between 2 and 18 years. The Subject Expert...

Keywords: Covaxin for children phase 2 trials, Covaxin for children breaking news, Subject Expert Committee, Covaxin for children trials

Read More